東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Organoids for personalised cancer medicine = a vision assessment of an emerging health technology /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Organoids for personalised cancer medicine/ by Henrik Vogt, Maxence Gaillard, Sara Green.
Reminder of title:	a vision assessment of an emerging health technology /
Author:	Vogt, Henrik.
other author:	Gaillard, Maxence.
Published:	Cham :Springer Nature Switzerland : : 2025.,
Description:	ix, 126 p. :ill. (some col.), digital ;24 cm.
[NT 15003449]:	Introduction -- Methodological development -- Vision analysis of patient-derived organoids for personalized cancer medicine -- Vision evaluation of patient-derived organoids in the clinic -- Conclusion.
Contained By:	Springer Nature eBook
Subject:	Cancer - Treatment -
Online resource:	https://doi.org/10.1007/978-3-031-85535-1
ISBN:	9783031855351

Organoids for personalised cancer medicine = a vision assessment of an emerging health technology /
Vogt, Henrik.

Organoids for personalised cancer medicinea vision assessment of an emerging health technology /[electronic resource] :by Henrik Vogt, Maxence Gaillard, Sara Green. - Cham :Springer Nature Switzerland :2025. - ix, 126 p. :ill. (some col.), digital ;24 cm. - SpringerBriefs in philosophy,2211-4556. - SpringerBriefs in philosophy..

Introduction -- Methodological development -- Vision analysis of patient-derived organoids for personalized cancer medicine -- Vision evaluation of patient-derived organoids in the clinic -- Conclusion.

Open access.

This open access book builds on and updates work performed in the HYBRIDA project, funded by the EU to develop an ethical framework for organoid research. Organoids are three-dimensional stem cell constructs that mimic organs of the body or tumours. Patient-derived organoids are envisioned to be grown from individual patients' tumours and used to tailor the most effective and safest treatments in a new form of personalized medicine. This text offers a critical assessment of this vision from the perspective of philosophy of medicine. The authors present a tailored "vision assessment", presented as examples of methodological development, and applied to objects. They first analyse and describe the vision of using organoids for personalized cancer medicine, then critically evaluate this vision and finally comment on ethical implications of the epistemological issues and how to handle them. The authors further draw on sources for empirical inquiries. This book presents an exercise in health technology assessment conducted by philosophers. Its core readership are philosophers of medicine and bioethicists interested in personalized medicine and stem cell research.

ISBN: 9783031855351

Standard No.: 10.1007/978-3-031-85535-1doiSubjects--Topical Terms:

3307943
Cancer
--Treatment

LC Class. No.: RC270.8

Dewey Class. No.: 616.99406

Organoids for personalised cancer medicine = a vision assessment of an emerging health technology /
LDR:02572nmm a2200373 a 4500 001 2412631
003 DE-He213
005 20250728130253.0
006 m d
007 cr nn 008maaau
008 260204s2025 sz s 0 eng d
020 $a 9783031855351 $q (electronic bk.)
020 $a 9783031855344 $q (paper)
024 7 $a 10.1007/978-3-031-85535-1 $2 doi
035 $a 978-3-031-85535-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.8
072 7 $a HP $2 bicssc
072 7 $a MBDC $2 bicssc
072 7 $a MED050000 $2 bisacsh
072 7 $a QD $2 thema
072 7 $a MBDC $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC270.8 $b .V886 2025
100 1 $a Vogt, Henrik. $3 3788122
245 1 0 $a Organoids for personalised cancer medicine $h [electronic resource] : $b a vision assessment of an emerging health technology / $c by Henrik Vogt, Maxence Gaillard, Sara Green.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2025.
300 $a ix, 126 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a SpringerBriefs in philosophy, $x 2211-4556
505 0 $a Introduction -- Methodological development -- Vision analysis of patient-derived organoids for personalized cancer medicine -- Vision evaluation of patient-derived organoids in the clinic -- Conclusion.
506 $a Open access.
520 $a This open access book builds on and updates work performed in the HYBRIDA project, funded by the EU to develop an ethical framework for organoid research. Organoids are three-dimensional stem cell constructs that mimic organs of the body or tumours. Patient-derived organoids are envisioned to be grown from individual patients' tumours and used to tailor the most effective and safest treatments in a new form of personalized medicine. This text offers a critical assessment of this vision from the perspective of philosophy of medicine. The authors present a tailored "vision assessment", presented as examples of methodological development, and applied to objects. They first analyse and describe the vision of using organoids for personalized cancer medicine, then critically evaluate this vision and finally comment on ethical implications of the epistemological issues and how to handle them. The authors further draw on sources for empirical inquiries. This book presents an exercise in health technology assessment conducted by philosophers. Its core readership are philosophers of medicine and bioethicists interested in personalized medicine and stem cell research.
650 0 $a Cancer $x Treatment $x Technological innovations. $3 3307943
650 0 $a Stem cells $x Therapeutic use. $3 1066248
650 0 $a Tissue engineering. $3 823582
650 1 4 $a Philosophy of Medicine. $3 894449
650 2 4 $a Clinical Medicine. $3 828964
650 2 4 $a Medical Ethics. $3 3541372
650 2 4 $a Philosophy of Technology. $3 897015
700 1 $a Gaillard, Maxence. $3 3788123
700 1 $a Green, Sara. $3 3220031
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a SpringerBriefs in philosophy. $3 1568619
856 4 0 $u https://doi.org/10.1007/978-3-031-85535-1
950 $a Religion and Philosophy (SpringerNature-41175)